drugset / Trial / NCT05147259
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of HR011408 at Two Formulations in Healthy Subject
RandomizedCrossoverDouble-blindTreatment
Summary
The objective of the study is to assess the safety, tolerability and pharmacokinetics of HR011408 at two formulations in healthy subject.
Timeline
- Start
- 2021-11-26
- Primary completion
- 2022-01-22
- Completion
- 2022-01-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HR011408 | Unknown | — | Subcutaneous |